Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6HOW

Trypanosoma brucei PTR1 in complex with the triazine inhibitor 2a (F219).

Summary for 6HOW
Entry DOI10.2210/pdb6how/pdb
Related6HNC 6HNR
DescriptorPteridine reductase, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, (2~{R})-1-(3,4-dichlorophenyl)-2-(4-nitrophenyl)-2~{H}-1,3,5-triazine-4,6-diamine, ... (5 entities in total)
Functional Keywordstrypanosoma brucei, pteridine reductase, ptr1, tbptr1, triazine inhibitors, oxidoreductase
Biological sourceTrypanosoma brucei brucei
More
Total number of polymer chains4
Total formula weight126806.38
Authors
Landi, G.,Pozzi, C.,Mangani, S. (deposition date: 2018-09-18, release date: 2019-05-08, Last modification date: 2024-01-24)
Primary citationLandi, G.,Linciano, P.,Borsari, C.,Bertolacini, C.P.,Moraes, C.B.,Cordeiro-da-Silva, A.,Gul, S.,Witt, G.,Kuzikov, M.,Costi, M.P.,Pozzi, C.,Mangani, S.
Structural Insights into the Development of Cycloguanil Derivatives asTrypanosoma bruceiPteridine-Reductase-1 Inhibitors.
Acs Infect Dis., 5:1105-1114, 2019
Cited by
PubMed Abstract: Cycloguanil is a known dihydrofolate-reductase (DHFR) inhibitor, but there is no evidence of its activity on pteridine reductase (PTR), the main metabolic bypass to DHFR inhibition in trypanosomatid parasites. Here, we provide experimental evidence of cycloguanil as an inhibitor of PTR1 (PTR1). A small library of cycloguanil derivatives was developed, resulting in and having IC values of 692 and 186 nM, respectively, toward PTR1. Structural analysis revealed that the increased potency of and is due to the combined contributions of hydrophobic interactions, H-bonds, and halogen bonds. Moreover, cell-growth-inhibition tests indicated that is also effective on . The simultaneous inhibition of DHFR and PTR1 activity in is a promising new strategy for the treatment of human African trypanosomiasis. For this purpose, 1,6-dihydrotriazines represent new molecular tools to develop potent dual PTR and DHFR inhibitors.
PubMed: 31012301
DOI: 10.1021/acsinfecdis.8b00358
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.92 Å)
Structure validation

238895

數據於2025-07-16公開中

PDB statisticsPDBj update infoContact PDBjnumon